Akshara Srivastava

Is Mankindss Pharma IPO worth a subscription? Here's what brokerages

In the grey markets, shares of Mankind Pharma enjoyed a premium of Rs 90, which translated to a likely listing price of Rs 1,170 per share on the upper price band

SBI Foundation hands out Rs 30 lakh grant in Shark Tank-like pitch fest

Fund given to eight fellows working on projects around health, governance, inclusion, farming

Air India building's high-flying days with a legacy changeover in order

India's first escalator, its shortest elevator, a terror attack, a rescue operation, the building's seen a lot

A slice of innovation: How bespoke is new buzz in the world of catering

For a series of dinners for Spotify's clients in India in November last year, Chandra blended food with music

'A step back': Tightened regulatory norms put crypto investors in a spot

Players from the crypto ecosystem believe at least this will create common standards, which in turn will make crypto assets much safer

Workplace imbalance hurting, expect employee engagement in 2023: Experts

With resignations and layoffs dominating trends post-Covid, HR leaders anticipate focus on employee engagement, hybrid work model and greater tech investment to improve efficiency

Rage rooms are all the rage but are they a healthy way of venting anger?

Places where people pay to smash things to let out their anger might just be a temporary fix, say experts

With baadshah back as Pathaan, here is what drives Brand Shah Rukh: Love

If the last few years dented his persona, Pathaan has shown it was just a fleeting phase

India Inc's yearly outlook 'most cautious in a decade': PwC survey

CEOs globally 'most pessimistic' on growth in 12 years, says PwC survey